Psych MEQs / SAQs · Foundations — EEG and clinical neurophysiology
EEG and clinical neurophysiology in psychiatry — MEQ
FRANZCP-style MEQ on psychiatric EEG indications, NCSE, clozapine, research biomarkers, and anti-NMDA EEG literacy.
On this page & tools
Target exams
Model answer
Reveal model answer
(i) Indications and normal EEG. Order EEG when organic differentials matter: atypical new psychosis, fluctuating cognition, suspected seizures, unexplained catatonia with medical concern, spell characterisation pathway. Routine EEG is not a universal screen for uncomplicated depression or anxiety. A normal EEG does not exclude epilepsy, encephalitis, or primary psychiatric illness; abnormal non-specific slowing is common and requires clinical correlation. Write a clear clinical question and drug list on the request. [1][2]
(ii) NCSE approach. Suspect NCSE with impaired awareness, fluctuating responsiveness, or mutism without full recovery — convulsions are not required. Escalate to urgent/continuous EEG with neurology/ICU rather than labelling pure functional mutism. Salzburg-style criteria combine EEG patterns with clinical context. Continuous EEG detects electrographic seizures missed on brief records in critically ill patients. Treat as medical emergency pathways while investigating cause. [3][4]
(iii) Clozapine. Clozapine is associated with higher rates of EEG abnormalities than many other antipsychotics and with clinically important dose-related seizures in large cohorts. Management: acute seizure care; review dose escalation, plasma level, smoking/cessation and interactions; consider dose adjustment and antiseizure prophylaxis discussion; do not abandon uniquely effective therapy without a joint plan. [5][6]
(iv) Research tools. Routine clinical EEG is a diagnostic aid for organic/epilepsy differentials. MMN reduction is a robust group finding in schizophrenia research on automatic auditory processing; P300 relates to attention/context updating research. qEEG spectral maps are not standalone DSM/ICD diagnostic tests in ordinary care. [1][7]
(v) Extreme delta brush. Distinctive pattern described in anti-NMDA receptor encephalitis; supportive not pathognomonic. Action: neurology pathway, antibody testing, imaging/LP as indicated, immunotherapy consideration — not primary schizophrenia closure. [8]
Common errors
Using normal EEG to prove functional illness; missing NCSE without convulsions; equating MMN with a bedside diagnostic test; ignoring clozapine dose/level after a seizure; treating extreme delta brush as pathognomonic without antibody work-up. [1][3][6][7][8]
References
- [1]O'Sullivan SS, Mullins GM, Cassidy EM, et al. The role of the standard EEG in clinical psychiatry Hum Psychopharmacol, 2006.PMID 16783810
- [2]Boutros NN A review of indications for routine EEG in clinical psychiatry Hosp Community Psychiatry, 1992.PMID 1516903
- [3]Beniczky S, Hirsch LJ, Kaplan PW, et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus Epilepsia, 2013.PMID 24001066
- [4]Herman ST, Abend NS, Bleck TP, et al. Consensus statement on continuous EEG in critically ill adults and children, part I: indications J Clin Neurophysiol, 2015.PMID 25626778
- [5]Centorrino F, Price BH, Tuttle M, et al. EEG abnormalities during treatment with typical and atypical antipsychotics Am J Psychiatry, 2002.PMID 11772698
- [6]Devinsky O, Honigfeld G, Patin J Clozapine-related seizures: experience with 5,629 patients Neurology, 1994.PMID 7991106
- [7]Umbricht D, Krljes S Mismatch negativity in schizophrenia: a meta-analysis Schizophr Res, 2005.PMID 15927795
- [8]Schmitt SE, Pargeon K, Frechette ES, et al. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis Neurology, 2012.PMID 22933737